Citation: | ZHOU Hui, SHAN Shucan. Dosimetry and passing rate of forward-intensity modulated radiation therapy and intensity modulated radiation therapy for left breast cancer patients with breast conserving surgery[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 15-18. DOI: 10.7619/jcmp.20200319 |
[1] |
陈万青, 郑荣寿, 张思维, 等. 2013年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2017, 26(1): 1-7. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201701001.htm
|
[2] |
陈万青, 孙可欣, 郑荣寿, 等. 2014年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2018, 27(1): 1-14. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201801001.htm
|
[3] |
孙可欣, 郑荣寿, 张思维, 等. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201901001.htm
|
[4] |
DARBY S, MCGALE P. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials[J]. Lancet, 2011, 378(9804): 1707-1716. doi: 10.1016/S0140-6736(11)61629-2
|
[5] |
COZZOLINO M, OLIVIERO C, CALIFANO G, et al. Clinically relevant quality assurance(QA)for prostate RapidArc plans: Gamma maps and DVH-based evaluation[J]. Physica Medica, 2014, 30(4): 462-472. doi: 10.1016/j.ejmp.2014.01.003
|
[6] |
International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photonbeam intensity-modulated radiation therapy(IMRT)[J]. Journal of the ICRU, 2010, 10(1): 1-106. http://www.ncbi.nlm.nih.gov/pubmed/24173332?report=medline&format=text
|
[7] |
CLEMENTE F, PEREZ C. SU-E-T-77: Comparison of 2D and 3D Gamma Analysis in Patient-Specific QA for Prostate VMAT Plans[J]. Medical Physics, 2014, 41(6Part12): 239-239. doi: 10.1118/1.4888407
|
[8] |
HUANG H, TSAI P, HUANG Y, et al. SU-E-T-183: Validation of COMPASS System for RapidArc Patient-Specific QA[J]. Medical Physics, 2011, 38(6): 3528. doi: 10.1118/1.3612133
|
[9] |
SDROLIA A, BROWNSWORD K M, MARSDEN J E, et al. Retrospective review of locally set tolerances for VMAT prostate patient specific QA using the COMPASS® system[J]. Physica Medica, 2015, 31: 792-797. doi: 10.1016/j.ejmp.2015.03.017
|
[10] |
GOLDBERG M, SUTRADHAR R, PASZAT L, et al. Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis[J]. Breast Cancer Research and Treatment, 2019, 176(4): 657-667. doi: 10.1007/s10549-019-05266-0
|
[11] |
HUANG X, CHEN Y, CHEN W, et al. Effect of radiotherapy after breast-conserving surgery in older patients with early breast cancer and breast ductal carcinomain situ: a meta-analysis[J]. Oncotarget, 2017, 8(17): 28215-28225. doi: 10.18632/oncotarget.15998
|
[12] |
GUPTA S, KING W D, KORZENIOWSKI M, et al. The Effect of Waiting Times for Postoperative Radiotherapy on Outcomes for Women Receiving Partial Mastectomy for Breast Cancer: a Systematic Review and Meta-Analysis[J]. Clinical Oncology, 2016, 28(12): 739-749. doi: 10.1016/j.clon.2016.07.010
|
[13] |
TSOUTSOU P G, KOUKOURAKIS M I, AZRIA D, et al. Optimal timing for adjuvant radiation therapy in breast cancer: A comprehensive review and perspectives[J]. Critical Reviews in Oncology/hematology, 2009, 71(2): 102-116. doi: 10.1016/j.critrevonc.2008.09.002
|
[14] |
黎艳萍, 陈卫东, 廖玲霞. 早期乳腺癌保乳术及术后治疗的研究进展[J]. 医学综述, 2013, 19(1): 69-71. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZS201301026.htm
|
[15] |
于金明, 李建彬. 乳腺癌保乳术后放射治疗进展[J]. 中华乳腺病志, 2007, 6(3): 13-22. https://www.cnki.com.cn/Article/CJFDTOTAL-SXZL201303073.htm
|